Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Chibale

Showing results (291-300 of 315) with videos related to

Pageof 32
Sort By:
Trends in Parasitology|March 2, 2021
MalDA, Accelerating Malaria Drug DiscoveryTuo Yang, Sabine Ottilie, Eva S Istvan, et al.
Journal of Medicinal Chemistry|October 27, 2015
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial ImidazopyridazinesClaire Le Manach, Tanya Paquet, Christel Brunschwig, et al.
Journal of Medicinal Chemistry|August 20, 2021
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in <i>Mycobacterium tuberculosis</i>Lutete Peguy Khonde, Rudolf Müller, Grant A Boyle, et al.
Angewandte Chemie (International Ed. in English)|October 24, 2025
Targeting Aurora Kinases as Essential Cell-Cycle Regulators to Deliver Multi-Stage Antimalarials Against Plasmodium FalciparumHenrico Langeveld, Keletso Maepa, Marché Maree, et al.
Journal of Medicinal Chemistry|October 26, 2020
Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse ModelAndré Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Journal of Medicinal Chemistry|January 28, 2021
Correction to "Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse Model"André Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Journal of Medicinal Chemistry|January 4, 2021
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action StudiesCandice Soares de Melo, Vinayak Singh, Alissa Myrick, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2018
Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarialsMariëtte E van der Watt, Janette Reader, Alisje Churchyard, et al.
Journal of Medicinal Chemistry|October 18, 2016
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life CycleClaire Le Manach, Aloysius T Nchinda, Tanya Paquet, et al.
ACS Omega|April 27, 2026
Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative StudyMelina Mottin, Christopher D Jurisch, Sabrina Silva-Mendonça, et al.
Pageof 32

Showing results (291-300 of 315) with videos related to

Sort By:
Pageof 32
Trends in Parasitology|March 2, 2021
MalDA, Accelerating Malaria Drug DiscoveryTuo Yang, Sabine Ottilie, Eva S Istvan, et al.
Journal of Medicinal Chemistry|October 27, 2015
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial ImidazopyridazinesClaire Le Manach, Tanya Paquet, Christel Brunschwig, et al.
Journal of Medicinal Chemistry|August 20, 2021
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in <i>Mycobacterium tuberculosis</i>Lutete Peguy Khonde, Rudolf Müller, Grant A Boyle, et al.
Angewandte Chemie (International Ed. in English)|October 24, 2025
Targeting Aurora Kinases as Essential Cell-Cycle Regulators to Deliver Multi-Stage Antimalarials Against Plasmodium FalciparumHenrico Langeveld, Keletso Maepa, Marché Maree, et al.
Journal of Medicinal Chemistry|October 26, 2020
Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse ModelAndré Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Journal of Medicinal Chemistry|January 28, 2021
Correction to "Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse Model"André Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Journal of Medicinal Chemistry|January 4, 2021
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action StudiesCandice Soares de Melo, Vinayak Singh, Alissa Myrick, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2018
Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarialsMariëtte E van der Watt, Janette Reader, Alisje Churchyard, et al.
Journal of Medicinal Chemistry|October 18, 2016
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life CycleClaire Le Manach, Aloysius T Nchinda, Tanya Paquet, et al.
ACS Omega|April 27, 2026
Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative StudyMelina Mottin, Christopher D Jurisch, Sabrina Silva-Mendonça, et al.
Pageof 32